Automated multi-dose dispensing in persons with and without Alzheimer's disease-impacts on pharmacotherapy.

ABSTRACT:

Purpose

We investigated the drug use before and after transition to automated multi-dose dispensing (MDD) service among persons with Alzheimer's disease (AD) and compared whether the changes were similar in persons without AD.

Methods

The register-based Finnish nationwide MEDALZ cohort includes 70,718 community-dwelling persons diagnosed with AD during 2005-2011. Each person who initiated MDD was matched in both groups with a comparison person without MDD by age, gender and for persons with AD, also time since AD diagnosis at the start of MDD. The study cohort included 15,604 persons with AD in MDD and 15,604 no-MDD, and 5224 persons without AD in MDD and 5224 no-MDD. Point prevalence of drug use was assessed every 3 months, from 1 year before to 2 years after the start of M

SUBMITTER: Vallius S 

PROVIDER: S-EPMC8818643 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature